Riverview Capital Advisers, LLC Abbott Laboratories Transaction History
Riverview Capital Advisers, LLC
- $291 Million
- Q2 2024
A detailed history of Riverview Capital Advisers, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Riverview Capital Advisers, LLC holds 1,925 shares of ABT stock, worth $219,180. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,925
Previous 1,959
1.74%
Holding current value
$219,180
Previous $222,000
9.91%
% of portfolio
0.07%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.47 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.18 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.52 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...